EUVIMEDEUVIMED entdecken
Crossref

Foveal atrophy in patients with active central serous chorioretinopathy at first presentation: characteristics and treatment outcomes

Ki Young Son, Seul Gi Lim, Sungsoon Hwang, Jaehwan Choi, Sang Jin Kim, Se Woong Kang

British Journal of Ophthalmology · 2025

DOI: 10.1136/bjo-2023-324147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Ophthalmology, 2025. Verfasst von Ki Young Son und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Chungnam National University Sejong Hospital, Sejong, Korea (the Republic of). Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Tomography, Optical Coherence, Fovea Centralis, Visual Acuity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aims This study aimed to investigate the clinical characteristics and treatment outcomes of patients with active central serous chorioretinopathy (CSC) and foveal atrophy.

Methods

Patients diagnosed with active idiopathic CSC using multimodal imaging and followed up for at least 6 months were included. They were divided into two groups (foveal atrophy group vs foveal non-atrophy group) according to a cut-off central foveal thickness of 120 µm on baseline optical coherence tomography (OCT). Baseline characteristics, angiographic and tomographic features and treatment outcomes were compared between the two groups.

Results

Of the 463 patients, 92 eyes of 92 patients (19.9%) were in the foveal atrophy group and 371 eyes of 371 patients (80.1%) were in the foveal non-atrophy group. The baseline subretinal fluid (SRF) height was 111.3±76.8 µm in the foveal atrophy group and 205.0±104.4 µm in the foveal non-atrophy group on OCT images (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Serous ChorioretinopathyTomography, Optical CoherenceFovea CentralisVisual AcuityAtrophyFluorescein AngiographySubretinal FluidHumansMaleFemaleMiddle AgedAdultRetrospective StudiesTreatment OutcomeFollow-Up StudiesMultimodal ImagingAngiogenesis InhibitorsIntravitreal InjectionsLaser CoagulationPhotochemotherapyRanibizumab

Stichwörter der Autor:innen

MaculaPrognosisRetina

Substanzen

Angiogenesis InhibitorsRanibizumab

Autor:innen und Institutionen

  • Department of Ophthalmology, Chungnam National University Sejong Hospital, Sejong, Korea (the Republic of).
  • Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (the Republic of).
  • Department of Ophthalmology, Kyung Hee University Medical Center, Kyung Hee University, Seoul, Korea (the Republic of).
  • Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (the Republic of) kangsewoong@gmail.com.

Zitieren

APA

Son, K. Y., Lim, S. G., Hwang, S., Choi, J., Kim, S. J., & Kang, S. W. (2025). Foveal atrophy in patients with active central serous chorioretinopathy at first presentation: characteristics and treatment outcomes. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2023-324147

Vancouver

Son KY, Lim SG, Hwang S, Choi J, Kim SJ, Kang SW. Foveal atrophy in patients with active central serous chorioretinopathy at first presentation: characteristics and treatment outcomes. British Journal of Ophthalmology. 2025. doi:10.1136/bjo-2023-324147

BibTeX
@article{Son2025,
  author = {Son, Ki Young and Lim, Seul Gi and Hwang, Sungsoon and Choi, Jaehwan and Kim, Sang Jin and Kang, Se Woong},
  title = {Foveal atrophy in patients with active central serous chorioretinopathy at first presentation: characteristics and treatment outcomes},
  journal = {British Journal of Ophthalmology},
  year = {2025},
  doi = {10.1136/bjo-2023-324147}
}
Kostenlos starten →